HCPCS Code Q2056
Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Short Description | Ciltacabtagene car-pos t |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | October 01, 2022 |
| Code Added Date | October 01, 2022 |
| Pricing Indicator | 51 = Drugs |
| Type of Service | 1 = Medical care P = Lump sum purchase of DME, prosthetics, orthotics |